Skip to content

VHCP Management III, LLC

Follow

13F filer, CIK 1738053, New York, NY

VHCP Management III, LLC reported $503,631,000 across 18 holdings for the quarter ended 2019-12-31, in a 13F-HR filed 2020-02-13. Its ten largest share positions make up 90.41% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-20-001882

Period
2019-12-31
Reported value
$504M
Holdings
18
Top 10 weight
90.41%
New
9
Sold out
8

Stakes and trades reported after 2019-12-31

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

  • OKUR ONKURE THERAPEUTICS INC: 13G 2,309,559 shares, 5.7% of the class, 13G filed 2026-11-20, 0001231919-26-001621Timeline
    Accepted , ingested
  • ENTX ENTERA BIO LTD: 13G 8,861,763 shares, 5.1% of the class, 13G filed 2026-10-30, 0001738048-26-000079Timeline
    Accepted , ingested
  • LYCA LYCIA THERAPEUTICS INC: 13G 6,850,237 shares, 11.9% of the class, 13G filed 2026-10-30, 0001738048-26-000077Timeline
    Accepted , ingested
  • FLSC FRAZIER LIFE SCIENCES ACQ-A: 13G 700,000 shares, 9% of the class, 13G filed 2026-10-27, 0001738048-26-000075Timeline
    Accepted , ingested
  • XFOR X4 PHARMACEUTICALS INC: 13G/A 7,644,072 shares, 7.6% of the class, 13G/A filed 2026-11-16, 0001738048-26-000100Timeline
    Accepted , ingested
  • VOR VOR BIOPHARMA INC: 13G/A 6,443,619 shares, 9.9% of the class, 13G/A filed 2026-11-16, 0001738048-26-000098Timeline
    Accepted , ingested
  • KRRO KORRO BIO INC: 13G/A 1,474,162 shares, 9.9% of the class, 13G/A filed 2026-11-16, 0001738048-26-000096Timeline
    Accepted , ingested
  • JBIO JADE BIOSCIENCES INC: 13G/A 3,858,984 shares, 5.9% of the class, 13G/A filed 2026-11-16, 0001738048-26-000094Timeline
    Accepted , ingested
  • HELP HELUS PHARMA INC: 13G/A 2,688,175 shares, 3.5% of the class, 13G/A filed 2026-11-16, 0001738048-26-000092Timeline
    Accepted , ingested
  • CBIO CRESCENT BIOPHARMA INC.: 13G/A 2,228,641 shares, 5.9% of the class, 13G/A filed 2026-11-16, 0001738048-26-000090Timeline
    Accepted , ingested
  • ACHV ACHIEVE LIFE SCIENCE INC: 13G/A 5,502,064 shares, 5.2% of the class, 13G/A filed 2026-11-16, 0001738048-26-000088Timeline
    Accepted , ingested

Largest buys vs the previous quarter

SecurityShares changeApprox. value
CONSTELLATION PHARMACEUTICALadded+2,449,575$115M
RLMDnew+767,938$29.9M
89BIO INCnew+958,765$25.2M
FORTY SEVEN INCnew+516,381$20.3M
INTRA-CELLULAR THERAPIES INCnew+575,000$19.7M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
RA PHARMACEUTICALS INCexited-670,350-$15.9M
LA JOLLA PHARMACEUTICAL COexited-1,251,898-$11M
BCRXexited-2,708,207-$7.76M
PTGXreduced-991,419-$7M
AXSMreduced-63,335-$6.55M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2019

Share positions as resolved from 13F-HR 0000950123-20-001882, largest first. % of portfolio is the value over $503,631,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: 1,068,044 shares; 2019Q2: 1,611,329 shares; 2019Q3: 1,611,329 shares; 2019Q4: 1,547,994 shares 1,547,994$160M31.77%-63,335Timeline
CONSTELLATION PHARMACEUTICALCONSTELLATION PHARMACEUTICALQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 66,667 shares; 2018Q4: 66,667 shares; 2019Q1: 66,667 shares; 2019Q2: 66,667 shares; 2019Q3: 66,667 shares; 2019Q4: 2,516,242 shares 2,516,242$119M23.54%+2,449,575
MISTMILESTONE PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: 2,066,529 shares; 2019Q3: 2,066,529 shares; 2019Q4: 2,066,529 shares 2,066,529$33.1M6.57%0Timeline
RLMDRELMADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: not reported; 2019Q4: 767,938 shares 767,938$29.9M5.95%newTimeline
89BIO INC89BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: not reported; 2019Q4: 958,765 shares 958,765$25.2M5%new
TXG10X GENOMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: 300,000 shares; 2019Q4: 300,000 shares 300,000$22.9M4.54%0Timeline
FORTY SEVEN INCFORTY SEVEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: not reported; 2019Q4: 516,381 shares 516,381$20.3M4.04%new
INTRA-CELLULAR THERAPIES INCINTRA-CELLULAR THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: not reported; 2019Q4: 575,000 shares 575,000$19.7M3.92%new
IVERIC BIO INCIVERIC BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: not reported; 2019Q4: 1,699,797 shares 1,699,797$14.6M2.9%new
KALVKALVISTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 1,284,931 shares; 2018Q4: 1,284,931 shares; 2019Q1: 970,630 shares; 2019Q2: 637,884 shares; 2019Q3: 637,884 shares; 2019Q4: 619,905 shares 619,905$11M2.19%-17,979Timeline
Adverum Biotechnologies, In…Adverum Biotechnologies, Inc.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: not reported; 2019Q4: 946,234 shares 946,234$10.9M2.16%new
MARINUS PHARMACEUTICALS INCMARINUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 672,271 shares; 2018Q4: 1,258,964 shares; 2019Q1: 1,258,964 shares; 2019Q2: 1,258,964 shares; 2019Q3: 2,516,164 shares; 2019Q4: 5,016,164 shares 5,016,164$10.8M2.15%+2,500,000
Mersana Therapeutics IncMersana Therapeutics IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: not reported; 2019Q4: 1,561,389 shares 1,561,389$8.95M1.78%new
MYOVANT SCIENCES LTDMYOVANT SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: not reported; 2019Q4: 455,255 shares 455,255$7.07M1.4%new
NEXTCURE INCNEXTCURE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: not reported; 2019Q4: 119,693 shares 119,693$6.74M1.34%new
ObsEva SAObsEva SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 1,159,789 shares; 2018Q4: 1,159,789 shares; 2019Q1: 1,159,789 shares; 2019Q2: 1,159,789 shares; 2019Q3: 1,159,789 shares; 2019Q4: 810,264 shares 810,264$3.1M0.61%-349,525
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: 423,176 shares; 2019Q1: 809,323 shares; 2019Q2: 1,072,348 shares; 2019Q3: 1,072,348 shares; 2019Q4: 80,929 shares 80,929$571K0.11%-991,419Timeline
BELLEROPHON THERAPEUTICS INCBELLEROPHON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 2,274,370 shares; 2018Q4: 2,274,370 shares; 2019Q1: 2,417,227 shares; 2019Q2: 2,417,227 shares; 2019Q3: 2,417,227 shares; 2019Q4: 383,955 shares 383,955$134K0.03%-2,033,272

Sold out in Q4 2019

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
RA PHARMACEUTICALS INCRA PHARMACEUTICALS INC670,350$15.9Mshares
LA JOLLA PHARMACEUTICAL COLA JOLLA PHARMACEUTICAL CO1,251,898$11Mshares
BCRXBIOCRYST PHARMACEUTICALS INC2,708,207$7.76Mshares
TRICIDA INCTRICIDA INC80,348$2.48Mshares
KINIKSA PHARMACEUTICALS LTDKINIKSA PHARMACEUTICALS LTD277,137$2.36Mshares
RADIUS HEALTH INCRADIUS HEALTH INC23,131$596Kshares
YUMANITY THERAPEUTICS INCYUMANITY THERAPEUTICS INC221,267$187Kshares
PREVAIL THERAPEUTICS INCPREVAIL THERAPEUTICS INC4,408$54Kshares

How Q4 2019 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-20-001882 base2020-02-13acceptance time not in the bulk data set